首頁 > 市場調查報告書 > 醫療設備

眼科設備

市場調查報告書

商品編碼

2008909

人工水晶體市場報告：按產品、材料、應用和地區分類（2026-2034 年）

Intraocular Lens Market Report by Product, Material (Polymethylmethacrylate, Silicone, Hydrophobic Acrylic), End Use, and Region 2026-2034

出版日期: 2026年04月01日 | 出版商:

IMARC | 英文 139 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄圖表

2025年，全球人工水晶體市場規模達46億美元。展望未來，IMARC Group預測，到2034年，該市場規模將達到67億美元，2026年至2034年的複合年成長率（CAGR）為4.14%。 2025年，北美市場佔據主導地位，這得益於其先進的醫療基礎設施和持續的技術創新。人口老化導致白內障發病率上升，加上全球眼科保健意識的增強和普及，推動了對先進手術治療的需求，從而提升了人工水晶體市場的佔有率。

市場規模及預測：

2025年，人工水晶體市場價值將達到46億美元。
預計從 2026 年到 2034 年，該市場將以 4.14% 的複合年成長率成長，到 2034 年達到 67 億美元。

主要部分：

產品：多焦點人工水晶體（IOL）憑藉其在不同距離提供清晰視力以及減少白內障手術後對眼鏡的依賴性，在市場上佔據主導地位。這使其成為追求便利性和提高生活品質人士的首選。
材質：疏水性丙烯酸酯因其優異的生物相容性、較低的後囊膜混濁風險和卓越的光學透明度而佔據最大的市場佔有率。其能夠保持長期穩定性並防止沉積，使其成為外科醫生的首選材料，從而改善白內障和屈光矯正手術的視覺效果和患者滿意度。
最終用途：該醫院作為白內障手術的主要中心，擁有最先進的手術設備和專業的眼科醫生，在市場上具有明顯的優勢。其管理大量患者的能力、提供全面的術前術後護理以及實施尖端的人工水晶體（IOL）技術，確保了對人工水晶體的穩定需求。
區域：北美市場佔據領先地位，這主要得益於其白內障高發病率、先進的醫療基礎設施以及高階人工水晶體的廣泛普及。完善的保險報銷機制、人們對視力矯正方案日益成長的認知以及主要市場參與者的存在，都進一步加速了該地區的成長。

主要企業：

人工水晶體市場的主要企業包括愛爾康、博士倫健康公司、卡爾蔡司醫療技術公司（卡爾蔡司基金會）、Icon Medical、HOYA Corporation、Human Optics、強生公司、Lenstec、Rayner Intraocular Lenses 和 Star Surgical。

市場成長的主要促進因素：

白內障發病率不斷上升，尤其是在老年族群中，這顯著推動了對人工水晶體（IOL）的需求。由於白內障仍然是全球視力障礙的主要原因之一，越來越多的患者需要接受手術治療。
眼科醫療設施的擴建：眼科醫療設施的快速擴建提高了白內障和屈光矯正手術的可及性，並增加了人工水晶體的使用。配備最新手術器械和技術精湛的專家的先進設施確保了更好的治療效果，吸引了更多患者前來就診。
生活型態相關眼科疾病激增：長時間使用電子螢幕正在加速年輕一代出現視力障礙，包括屈光不正。這一趨勢擴大了人工水晶體植入手術的潛在患者群。眼部疲勞、藍光照射和戶外活動減少是推動矯正手術需求的主要因素。
技術進步：人工水晶體（IOL）的創新，例如多焦點晶狀體、散光矯正水晶體和調節型水晶體，顯著提高了視力，並減少了對眼鏡的依賴。先進的影像技術和雷射輔助技術提高了手術精度，從而提升了患者滿意度。
擴大眼科治療的保險覆蓋範圍：擴大白內障手術和人工水晶體植入的保險覆蓋範圍，降低了經濟門檻，使更多人能夠獲得治療。保險報銷制度鼓勵及時手術，並允許患者選擇優質晶體。

未來展望：

強勁成長前景：受白內障患者數量不斷增加、人口老化以及先進晶體技術廣泛應用等因素的推動，人工水晶體市場預計將持續成長。醫療保健覆蓋範圍的擴大、保險政策的完善以及技術創新有望增加手術數量，並進一步加速全球市場普及。
市場演變：預計該領域將從基礎的單焦點鏡片轉向先進的多焦點鏡片、散光鏡片和可調節鏡片，以增強視力矯正效果。雷射輔助手術和高階鏡片客製化等技術的融合，徹底改變了治療標準。

推動這一市場發展的因素包括患者對多焦點和散光鏡片等先進視力矯正方案的認知度不斷提高。文明病相關眼科疾病（尤其是長時間使用電子螢幕導致的眼疾）的增加，是導致視力障礙並需要手術介入的重要因素。眼科手術保險覆蓋範圍的擴大和優惠的報銷政策，使得更多人能夠負擔得起人工水晶體手術。此外，年輕一代選擇性地進行屈光晶體置換術以矯正視力的趨勢，也擴大了市場規模。製造商和眼科醫師加強行銷力度，強調先進人工水晶體的優勢，也影響病人的選擇。最後，手術安全性和效果的提升，也促使更多人選擇晶體置換術。

人工水晶體市場趨勢：

白內障患病率增加

白內障盛行率的上升，尤其是在老年族群中，是推動市場成長的主要因素。根據美國疾病管制與預防中心（CDC）預測，到2028年，美國將有超過3,000萬人罹患白內障。白內障會導致水晶體混濁，進而造成視力障礙，而手術是目前唯一的矯正方法。隨著全球老年人口的成長，白內障手術的數量顯著增加，從而推動了對人工水晶體（IOL）的需求。公共衛生措施和政府提供的免費或津貼白內障手術計畫正在改善患者獲得治療的機會。手術技術的進步和成功率的提高，促使更多患者選擇白內障摘除手術，直接促進了人工水晶體的全球普及。

眼科醫療中心擴建

眼科醫療中心的擴建有助於提高專業眼科服務的可近性。 2025年7月，由董事長兼執行長D. Ramamurti創立的眼科基金會（Eye Foundation）——一個由多家高度專業化的眼科醫院組成的網路——在印度清奈的瓦達帕拉尼開設了其第25家分院。該中心提供包括使用高階人工晶體（IOL）的雷射白內障手術以及SILK和飛秒雷射等尖端LASIK技術在內的專業服務。都市區地區醫院、診所和專業眼科醫療機構的增加，使得更多人能夠獲得白內障和屈光矯正手術。基礎設施的改善使得及時診斷和治療成為可能，這對於白內障等需要手術治療的疾病至關重要。這些先進醫療中心的建立增強了患者對手術的信心，並鼓勵更多人選擇視力矯正。

技術進步

技術進步透過為患者提供更佳的視力矯正和更廣泛的客製化選擇，推動了市場成長。多焦點晶體、景深擴展晶體、散光鏡片和調節型人工水晶體（IOL）等創新技術能夠更有效地矯正老花眼和散光，從而減少對眼鏡的依賴。晶體材料的進步提高了生物相容性並減少了術後併發症，而飛秒雷射白內障手術等精準的手術技術則提高了晶體植入的準確性。 2025年1月，北京億博醫療科技有限公司及其子公司宣布，其用於有晶狀體眼患者的龍晶PR人工水晶體已獲得國家藥品監督管理局（NMPA）頒發的III類醫療設備認證。龍晶PR採用先進的均衡丙烯酸酯材料製成，具有無球面像差設計、寬光學區和穩定的雙凹弓形高度。此外，透過整合數位影像處理和人工智慧（AI）規劃工具，外科醫師可以實現針對每位患者個別需求的最佳屈光矯正效果。

文明病引起的眼科疾病急劇增加。

長時間使用電子螢幕導致的與文明病的眼科疾病發病率不斷上升，正在改善市場前景。過度使用電腦、智慧型手機和電子設備會導致眼睛疲勞、乾眼症和視力加速下降，從而加速水晶體相關疾病的發生。視力障礙過去常見於老年人，如今也出現在年輕一代中，這擴大了人工水晶體植入術的潛在患者群體。此外，持續暴露於藍光和戶外活動減少也會影響整體眼部健康，因此需要採取矯正措施。眼科專家建議及時進行手術干預以恢復視力，其中許多手術都涉及植入先進的人工水晶體。這些生活方式的改變正在推動對視力矯正手術的持續需求，從而促進市場成長。

人們對先進視力矯正方案的認知不斷提高

隨著人們對先進視力矯正方案的認知不斷提高，人工水晶體（IOL）的需求也隨之成長，因為患者正在尋求恢復清晰視力的長期解決方案。宣傳活動和社群媒體推廣正在提升大眾對白內障手術和屈光水晶體置換術的了解。許多人開始意識到，人工水晶體不僅可以矯正白內障，還可以矯正近視、遠視和散光等屈光不正。口碑傳播、患者證詞以及眼科醫生提供的透明資訊進一步增強了人們對這些手術的信心。隨著患者了解到有優質的人工水晶體可供選擇，從而減少對眼鏡的依賴，他們擴大選擇更早接受手術。這種認知的提高，加上健康意識的增強，直接推動了人工水晶體植入率的提高和市場的穩定成長。

擴大眼科治療的保險覆蓋範圍

眼科治療保險覆蓋範圍的擴大對市場產生了積極影響，顯著降低了視力矯正手術的經濟門檻。許多健康保險計劃現在涵蓋部分或全部白內障手術費用，包括人工水晶體（IOL）的費用。這使得更多人群，包括退休人員和低收入患者，能夠更方便地獲得先進的人工水晶體。此外，一些國家的保險報銷機制鼓勵患者及時接受手術，以防止視力喪失並提高生活品質。透過減少自付費用，保險覆蓋使患者能夠選擇具有更佳視覺效果的高階人工水晶體。這不僅提高了市場滲透率，也提升了每次手術的平均收入。隨著保險政策不斷擴大眼科治療的覆蓋範圍，預計對人工水晶體的需求將穩定成長。

The global intraocular lens market size reached USD 4.6 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 6.7 Billion by 2034, exhibiting a growth rate (CAGR) of 4.14% during 2026-2034. North America dominates the market in 2025, driven by advanced healthcare infrastructure and continual technological innovations . The growing aging population with increased cataract incidence and rising global awareness and accessibility to eye care are collectively driving the demand for advanced surgical interventions, thereby propelling the intraocular lens market share.

MARKET SIZE & FORECASTS:

Intraocular lens market was valued at USD 4.6 Billion in 2025.
The market is projected to reach USD 6.7 Billion by 2034, at a CAGR of 4.14% from 2026-2034.

DOMINANT SEGMENTS:

Product: Multifocal intraocular lens (IOL) dominates the market because it provides sharp vision at various distances, decreasing the reliance on glasses post-cataract surgery. This renders it a favored option for individuals looking for ease and improved living standards.
Material: Hydrophobic acrylic represents the biggest market share due to its outstanding biocompatibility, low likelihood of posterior capsule opacification, and superior optical clarity. Its capacity to uphold long-term stability and prevent deposits makes it the preferred material for surgeons, enhancing visual results and patient satisfaction in cataract and refractive surgeries.
End Use: Hospitals exhibit a clear dominance in the market as they act as main hubs for cataract operations, possess state-of-the-art surgical equipment, and hire expert ophthalmologists. Their capacity to manage large patient numbers, provide thorough pre- and post-operative care, and implement cutting-edge intraocular lens (IOL) technologies guarantees a steady need for IOLs.
Region: North America leads the market due to high prevalence of cataracts, advanced healthcare infrastructure, and widespread adoption of premium IOLs. Strong reimbursement systems, higher awareness about vision correction options, and the presence of key market players are further accelerating the region's growth.

KEY PLAYERS:

The leading companies in intraocular lens market include Alcon Inc., Bausch Health Companies Inc., Carl Zeiss Meditec AG (Carl-Zeiss-Stiftung), EyeKon Medical Inc., Hoya Corporation, HumanOptics AG, Johnson & Johnson, Lenstec Inc., Rayner Intraocular Lenses Limited, STAAR Surgical Company, etc.

KEY DRIVERS OF MARKET GROWTH:

Increasing Prevalence of Cataracts: Rising prevalence of cataracts, especially among the aging population, is significantly driving the demand for IOLs. As cataracts remain the leading cause of vision impairment globally, more patients require surgical intervention.
Expansion of Ophthalmic Care Centers: The rapid expansion of ophthalmic care centers is enhancing access to cataract and refractive surgeries, increasing IOL adoption. Advanced facilities equipped with modern surgical tools and trained specialists ensure better outcomes, encouraging more patients to seek treatment.
Surge in Lifestyle-related Eye Conditions: Prolonged screen use is accelerating the onset of vision problems, including refractive errors, among younger individuals. This trend is expanding the potential patient base for IOL surgeries. Eye strain, blue light exposure, and reduced outdoor activities are driving the demand for corrective procedures.
Technological Advancements: Technological innovations in IOLs, such as multifocal, toric, and accommodating designs, provide superior visual outcomes and reduced dependence on glasses. Enhanced surgical precision through advanced imaging and laser-assisted techniques improves patient satisfaction.
Increasing Insurance Coverage for Eye Treatments: Rising insurance coverage for cataract surgeries and IOLs reduces financial barriers, making treatments accessible to wider populations. Reimbursement policies are encouraging timely procedures and enabling patients to choose premium lens options.

FUTURE OUTLOOK:

Strong Growth Outlook: The intraocular lens market is anticipated to experience sustained expansion, driven by increasing cataract cases, aging population, and rising adoption of advanced lens technologies. Expanding healthcare access, supportive insurance policies, and technological innovations are expected to enhance surgical volumes, ensuring greater global penetration.
Market Evolution: The sector is anticipated to shift from basic monofocal designs to advanced multifocal, toric, and accommodating lenses, offering improved visual outcomes. Technological integration, such as laser-assisted surgery and premium lens customization, has transformed treatment standards.

The market is driven by the growing awareness among patients about advanced vision correction options, such as multifocal and toric lenses. Rising lifestyle-related eye conditions, particularly due to prolonged screen exposure, are contributing to vision impairments requiring surgical intervention. Increasing insurance coverage and favorable reimbursement policies for eye surgeries are making IOLs more accessible to a broader population. Additionally, the trend of refractive lens exchange for elective vision correction among younger individuals is widening the market base. Greater marketing efforts by manufacturers and ophthalmologists to highlight the benefits of advanced IOLs are also influencing patient choices. Furthermore, improvements in surgical safety and outcomes are encouraging more people to opt for lens replacement procedures.

INTRAOCULAR LENS MARKET TRENDS:

Increasing prevalence of cataracts

Rising prevalence of cataracts, especially among the aging population, is a major driver for the market. As per the Centers for Disease Control and Prevention (CDC), by the year 2028, it is anticipated that more than 30 Million individuals will be affected by cataracts in the United States. Cataracts cause clouding of the natural lens, leading to vision impairment that can only be corrected through surgery. As the global elderly demographic is growing, the number of cataract surgeries is increasing significantly, driving the demand for IOLs. Public health initiatives and government programs offering free or subsidized cataract surgeries are making treatments more accessible. With improved surgical techniques and higher success rates, more patients are opting for cataract removal, directly fueling the adoption of IOLs worldwide.

Expansion of ophthalmic care centers

The broadening of ophthalmic care centers is aiding in improving accessibility to specialized eye treatments. In July 2025, the Eye Foundation, a network of super-speciality eye hospitals established by D. Ramamurthy, chairman and managing director, inaugurated its 25th facility in Vadapalani, Chennai, India. The center provided specialized services, such as laser cataract surgery featuring premium IOLs and cutting-edge LASIK technologies like SILK and Femto. With more hospitals, clinics, and dedicated eye care facilities opening in both urban and rural areas, a larger population can undergo cataract and refractive surgeries. This improved infrastructure enables timely diagnosis and treatment, which is crucial for conditions like cataracts that require surgical intervention. The presence of advanced care centers is boosting patient confidence in surgical procedures, encouraging more individuals to opt for vision correction.

Technological advancements

Technological advancements are propelling the market growth by offering patients improved visual outcomes and greater customization options. Innovations, such as multifocal, extended depth-of-focus, toric lenses, and accommodating IOLs, provide better correction for presbyopia and astigmatism, reducing dependence on glasses. Advancements in lens materials enhance biocompatibility and reduce post-surgical complications, while precision surgical techniques like femtosecond laser-assisted cataract surgery increase implantation accuracy. In January 2025, Yebright Medical Technology (Beijing) Co., Ltd., along with its subsidiaries, declared that its Phakic IOL, 'Loong Crystal PR,' obtained the Class III Medical Devices Certificate from the National Medical Products Administration (NMPA). Made from an advanced, balanced acrylic material, the Loong Crystal PR featured a zero spherical aberration layout with an extensive optical zone and a stable double concave arch height configuration. Besides this, the integration of digital imaging and artificial intelligence (AI)-based planning tools allows surgeons to achieve optimal refractive results tailored to individual patient needs.

Surge in lifestyle-related eye conditions

Increasing incidence of lifestyle-related eye conditions caused by prolonged screen time is offering a favorable market outlook. Excessive use of computers, smartphones, and digital devices leads to eye strain, dry eyes, and accelerated vision deterioration, contributing to the earlier onset of lens-related disorders. Younger individuals are now experiencing vision impairment that traditionally affected older adults, expanding the potential patient base for IOL surgeries. Additionally, constant exposure to blue light and reduced outdoor activities are known to affect overall eye health, necessitating corrective procedures. Eye care professionals are recommending timely surgical interventions to restore vision, which often involve the implantation of advanced IOLs. This lifestyle shift is catalyzing sustained demand for corrective eye surgeries, thereby fueling the market growth.

Growing awareness about advanced vision correction options

Rising awareness about advanced vision correction options is driving the demand for IOLs, as patients are seeking long-term solutions to restore clear vision. Educational programs and social media outreach have made people more informed about cataract surgery and refractive lens exchange. Many individuals are understanding that IOLs not only treat cataracts but can also correct refractive errors like myopia, hyperopia, and astigmatism. Word-of-mouth recommendations, testimonials, and transparent communication from ophthalmologists further build trust in these procedures. As patients are learning about the availability of premium lens types offering reduced dependence on glasses, they are more likely to choose surgical intervention earlier. This heightened awareness, combined with increased health consciousness, is directly translating into higher adoption rates, thereby impelling steady market growth.

Increasing insurance coverage for eye treatments

Rising insurance coverage for eye treatments is positively influencing the market, as it significantly reduces the financial barrier to vision correction surgeries. Many health insurance policies include partial or full coverage for cataract procedures, including the cost of IOLs. This makes advanced lens options more accessible to a broader demographic, including retirees and low-income patients. Reimbursement policies in several countries also encourage timely surgery, preventing vision loss and improving quality of life. By alleviating out-of-pocket expenses, insurance coverage allows patients to opt for premium IOLs with enhanced visual performance. This is not only boosting the market penetration but also increasing the average revenue per surgery. As insurance policies continue to expand their scope for ophthalmic treatments, the demand for IOLs is expected to grow steadily.

INTRAOCULAR LENS INDUSTRY SEGMENTATION:

Breakup by Product:

Monofocal IOL
Multifocal IOL
Toric IOL
Accommodative IOL

Multifocal IOL account for the majority of the market share

Multifocal IOLs dominate the market as the largest segment, offering a comprehensive solution to age-related vision issues. These lenses provide multiple focal points, allowing patients to achieve clear vision at various distances, reducing dependence on glasses after cataract surgery. With an aging population seeking enhanced visual acuity for both near and far distances, multifocal IOLs have gained prominence. The versatility they offer aligns with the lifestyle demands of individuals desiring improved vision across different activities, from reading to driving, making them a preferred choice in the market.

Monofocal IOLs represent a significant segment of the market, serving as a traditional and cost-effective option for cataract surgery. These lenses have a single focal point, typically set for distance vision, necessitating the use of glasses for activities requiring near vision. While lacking multifocal versatility, monofocal IOLs remain popular due to their reliability and affordability, catering to patients with specific visual needs and budget constraints.

Toric IOLs address astigmatism, a common refractive error, making them a crucial segment in the market. These lenses correct both cataracts and astigmatism simultaneously, enhancing visual outcomes for patients with irregular corneal shapes. With an increasing prevalence of astigmatism globally, toric IOLs have witnessed growing demand, offering patients the opportunity to achieve better visual clarity without additional surgical interventions or reliance on corrective eyewear.

Accommodative IOLs represent an innovative segment designed to mimic the eye's natural ability to adjust focus. These lenses provide a dynamic range of vision by changing shape and position within the eye. While still evolving, accommodative IOLs aim to reduce dependency on glasses for both near and distant vision. As technological advancements continue, this segment holds promise for individuals seeking a more adaptive and natural visual experience post-cataract surgery.

Breakup by Material:

Polymethylmethacrylate (PMMA)
Silicone
Hydrophobic Acrylic

Hydrophobic acrylic holds the largest share of the industry

Hydrophobic acrylic has emerged as the largest segment in the market due to its superior optical properties and biocompatibility. These lenses are known for their resistance to protein and water deposits, reducing the likelihood of postoperative complications. Hydrophobic acrylic IOLs provide excellent clarity and are suitable for various surgical techniques. Surgeons often prefer this material for its ease of handling and the reduced risk of posterior capsule opacification (PCO), contributing to the widespread adoption of hydrophobic acrylic lenses in modern cataract surgeries. The material's ability to maintain optical clarity over time and resist clouding has solidified its position as a leading choice.

PMMA has been a traditional material in intraocular lenses (IOLs) and, while its usage has decreased with technological advancements, it still holds a notable segment in the market. PMMA lenses are rigid and durable, providing stability within the eye. However, their lack of flexibility and potential for certain postoperative complications have led to a decline in their popularity compared to more modern materials like hydrophobic acrylic and silicone.

Silicone lenses offer flexibility and biocompatibility, contributing to their prevalence in the market. Known for their softness and ability to fold easily, silicone lenses facilitate less invasive surgical procedures. The material's inert nature reduces the risk of inflammation and allergic reactions. While not as widely used as hydrophobic acrylic, silicone remains a significant choice, particularly in cases where the surgeon prioritizes lens flexibility and patient comfort.

Breakup by End Use:

Hospitals
Ophthalmic Clinics
Ambulatory Care Centers
Eye Research Institutes

Hospitals represent the leading market segment

Hospitals constitute the largest segment of the market, serving as primary hubs for surgical procedures, including cataract surgeries requiring IOL implantation. The comprehensive infrastructure and diverse medical specialties within hospitals make them central to the diagnosis and treatment of ocular conditions. The high patient footfall in hospitals, coupled with the availability of advanced surgical facilities, positions them as key contributors to the demand for intraocular lenses. Moreover, hospitals often attract a wide range of patients, including those with complex ocular conditions, making them pivotal in the overall market share.

On the other hand, ophthalmic clinics represent a significant segment of the market, offering specialized care focused on eye health. These clinics, led by ophthalmologists and optometrists, are key contributors to the diagnosis and treatment of various eye disorders, including cataracts. Ophthalmic clinics provide a more specialized and focused environment for eye care, attracting patients seeking expert advice and surgical interventions. The efficiency and expertise of these clinics contribute to their substantial share in the IOL market, particularly for routine and elective eye surgeries.

Moreover, ambulatory care centers play a notable role in the market, offering a balance between the comprehensive services of hospitals and the specialized care of ophthalmic clinics. These centers provide outpatient surgical procedures, including cataract surgery with this lens implantation. The convenience of ambulatory care centers, offering timely and efficient procedures without the need for overnight hospital stays, appeals to patients and contributes to the demand for these lenses outside traditional hospital settings.

Furthermore, eye research institutes are crucial contributors to the market. These institutions focus on advancing knowledge in ophthalmology, developing new surgical techniques, and conducting clinical trials for innovative intraocular lens technologies. The insights and advancements generated by eye research institutes influence the broader market, shaping the future of these lens materials, designs, and surgical approaches. While not primary end-users for routine surgeries, these institutes play a pivotal role in driving innovation and elevating the standards of care in the field of ophthalmology.

Breakup by Region:

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
Latin America
- Brazil
- Mexico
- Others
Middle East and Africa

North America leads the market, accounting for the largest intraocular lens market share

The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.

North America dominates the market, driven by advanced healthcare infrastructure, a high prevalence of cataracts, and a rapidly aging population. The region's well-established reimbursement policies and a strong focus on technological innovations contribute to the widespread adoption of premium IOLs. The presence of key market players, coupled with a proactive approach toward eye health and surgical interventions, solidifies North America's leading position in the global IOL market.

The Asia Pacific region is a significant and growing market for intraocular lenses, fueled by a large population, increasing awareness of eye health, and rising access to healthcare services. The prevalence of age-related eye conditions, including cataracts, in countries like China and India, propels the demand for IOLs. Furthermore, advancements in healthcare infrastructure and the growing disposable income in several Asia Pacific nations contribute to the expansion of the market in the region.

Europe stands as a prominent market for these lenses, driven by a well-established healthcare system, a high prevalence of age-related eye disorders, and a growing emphasis on minimally invasive surgical techniques. The region's aging population contributes significantly to the demand for cataract surgeries and, consequently, intraocular lenses. European countries also exhibit a strong inclination toward adopting innovative medical technologies, fostering the growth of the market in the region.

Latin America represents a burgeoning market for intraocular lenses, propelled by improving healthcare infrastructure and a rising awareness of eye health. The region's aging demographic contributes to an increased incidence of cataracts, driving the demand for lens implantation. While the market is still developing, Latin America showcases substantial growth potential, with increasing investments in healthcare and a growing focus on addressing visual impairments.

The Middle East and Africa exhibit a growing demand for these lenses, driven by improving healthcare accessibility and rising awareness of eye disorders. Although the market is in the early stages of development compared to other regions, an aging population and increasing investments in healthcare infrastructure contribute to the expansion of the market. As these regions continue to advance in medical technology adoption, the demand for intraocular lenses is expected to rise, albeit at a pace influenced by regional economic factors and healthcare development.

LEADING KEY PLAYERS IN THE INTRAOCULAR LENS INDUSTRY:

The key players in the market are actively engaged in strategic initiatives to maintain and expand their market presence. Continuous research and development efforts are directed towards the enhancement of intraocular lens technologies, focusing on improving optical outcomes, durability, and patient satisfaction. Companies are investing in the development of innovative materials and designs, such as advanced hydrophobic acrylics and multifocal lenses, to address evolving patient needs. Additionally, strategic collaborations, partnerships, and acquisitions are prevalent among key players, enabling them to strengthen their product portfolios and leverage complementary technologies. Market leaders are also actively involved in geographic expansion, targeting emerging markets with growing healthcare infrastructures.

The market research report has provided a comprehensive analysis of the competitive landscape. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

Alcon Inc.
Bausch Health Companies Inc.
Carl Zeiss Meditec AG (Carl-Zeiss-Stiftung)
EyeKon Medical Inc.
Hoya Corporation
HumanOptics AG
Johnson & Johnson
Lenstec Inc.
Rayner Intraocular Lenses Limited
STAAR Surgical Company

Key Questions Answered in This Report

1.What is the expected growth rate of the global intraocular lens market during 2026-2034?
2.What are the key factors driving the global intraocular lens market?
3.What has been the impact of COVID-19 on the global intraocular lens market?
4.What is the breakup of the global intraocular lens market based on the product?
5.What is the breakup of the global intraocular lens market based on the material?
6.What is the breakup of the global intraocular lens market based on the end use?
7.What are the key regions in the global intraocular lens market?
8.Who are the key players/companies in the global intraocular lens market?

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

4.1 Overview
4.2 Key Industry Trends

5 Global Intraocular Lens Market

5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast

6 Market Breakup by Product

6.1 Monofocal IOL
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
6.2 Multifocal IOL
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
6.3 Toric IOL
- 6.3.1 Market Trends
- 6.3.2 Market Forecast
6.4 Accommodative IOL
- 6.4.1 Market Trends
- 6.4.2 Market Forecast

7 Market Breakup by Material

7.1 Polymethylmethacrylate (PMMA)
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
7.2 Silicone
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
7.3 Hydrophobic Acrylic
- 7.3.1 Market Trends
- 7.3.2 Market Forecast

8 Market Breakup by End Use

8.1 Hospitals
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
8.2 Ophthalmic Clinics
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
8.3 Ambulatory Care Centers
- 8.3.1 Market Trends
- 8.3.2 Market Forecast
8.4 Eye Research Institutes
- 8.4.1 Market Trends
- 8.4.2 Market Forecast

9 Market Breakup by Region

9.1 North America
- 9.1.1 United States
  - 9.1.1.1 Market Trends
  - 9.1.1.2 Market Forecast
- 9.1.2 Canada
  - 9.1.2.1 Market Trends
  - 9.1.2.2 Market Forecast
9.2 Asia-Pacific
- 9.2.1 China
  - 9.2.1.1 Market Trends
  - 9.2.1.2 Market Forecast
- 9.2.2 Japan
  - 9.2.2.1 Market Trends
  - 9.2.2.2 Market Forecast
- 9.2.3 India
  - 9.2.3.1 Market Trends
  - 9.2.3.2 Market Forecast
- 9.2.4 South Korea
  - 9.2.4.1 Market Trends
  - 9.2.4.2 Market Forecast
- 9.2.5 Australia
  - 9.2.5.1 Market Trends
  - 9.2.5.2 Market Forecast
- 9.2.6 Indonesia
  - 9.2.6.1 Market Trends
  - 9.2.6.2 Market Forecast
- 9.2.7 Others
  - 9.2.7.1 Market Trends
  - 9.2.7.2 Market Forecast
9.3 Europe
- 9.3.1 Germany
  - 9.3.1.1 Market Trends
  - 9.3.1.2 Market Forecast
- 9.3.2 France
  - 9.3.2.1 Market Trends
  - 9.3.2.2 Market Forecast
- 9.3.3 United Kingdom
  - 9.3.3.1 Market Trends
  - 9.3.3.2 Market Forecast
- 9.3.4 Italy
  - 9.3.4.1 Market Trends
  - 9.3.4.2 Market Forecast
- 9.3.5 Spain
  - 9.3.5.1 Market Trends
  - 9.3.5.2 Market Forecast
- 9.3.6 Russia
  - 9.3.6.1 Market Trends
  - 9.3.6.2 Market Forecast
- 9.3.7 Others
  - 9.3.7.1 Market Trends
  - 9.3.7.2 Market Forecast
9.4 Latin America
- 9.4.1 Brazil
  - 9.4.1.1 Market Trends
  - 9.4.1.2 Market Forecast
- 9.4.2 Mexico
  - 9.4.2.1 Market Trends
  - 9.4.2.2 Market Forecast
- 9.4.3 Others
  - 9.4.3.1 Market Trends
  - 9.4.3.2 Market Forecast
9.5 Middle East and Africa
- 9.5.1 Market Trends
- 9.5.2 Market Breakup by Country
- 9.5.3 Market Forecast

10 SWOT Analysis

10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
- 14.3.1 Alcon Inc.
  - 14.3.1.1 Company Overview
  - 14.3.1.2 Product Portfolio
  - 14.3.1.3 Financials
- 14.3.2 Bausch Health Companies Inc.
  - 14.3.2.1 Company Overview
  - 14.3.2.2 Product Portfolio
  - 14.3.2.3 Financials
  - 14.3.2.4 SWOT Analysis
- 14.3.3 Carl Zeiss Meditec AG (Carl-Zeiss-Stiftung)
  - 14.3.3.1 Company Overview
  - 14.3.3.2 Product Portfolio
  - 14.3.3.3 Financials
  - 14.3.3.4 SWOT Analysis
- 14.3.4 EyeKon Medical Inc.
  - 14.3.4.1 Company Overview
  - 14.3.4.2 Product Portfolio
- 14.3.5 Hoya Corporation
  - 14.3.5.1 Company Overview
  - 14.3.5.2 Product Portfolio
  - 14.3.5.3 Financials
  - 14.3.5.4 SWOT Analysis
- 14.3.6 HumanOptics AG
  - 14.3.6.1 Company Overview
  - 14.3.6.2 Product Portfolio
  - 14.3.6.3 Financials
- 14.3.7 Johnson & Johnson
  - 14.3.7.1 Company Overview
  - 14.3.7.2 Product Portfolio
  - 14.3.7.3 Financials
  - 14.3.7.4 SWOT Analysis
- 14.3.8 Lenstec Inc.
  - 14.3.8.1 Company Overview
  - 14.3.8.2 Product Portfolio
- 14.3.9 Rayner Intraocular Lenses Limited
  - 14.3.9.1 Company Overview
  - 14.3.9.2 Product Portfolio
- 14.3.10 STAAR Surgical Company
  - 14.3.10.1 Company Overview
  - 14.3.10.2 Product Portfolio
  - 14.3.10.3 Financials

簡介目錄圖表

List of Figures

Figure 1: Global: Intraocular Lens Market: Sales Value (in Billion USD), 2020-2025
Figure 2: Global: Intraocular Lens Market Forecast: Sales Value (in Billion USD), 2026-2034
Figure 3: Global: Intraocular Lens Market: Breakup by Product (in %), 2025
Figure 4: Global: Intraocular Lens Market: Breakup by Material (in %), 2025
Figure 5: Global: Intraocular Lens Market: Breakup by End Use (in %), 2025
Figure 6: Global: Intraocular Lens Market: Breakup by Region (in %), 2025
Figure 7: Global: Intraocular Lens (Monofocal IOL) Market: Sales Value (in Million USD), 2020 & 2025
Figure 8: Global: Intraocular Lens (Monofocal IOL) Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 9: Global: Intraocular Lens (Multifocal IOL) Market: Sales Value (in Million USD), 2020 & 2025
Figure 10: Global: Intraocular Lens (Multifocal IOL) Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 11: Global: Intraocular Lens (Toric IOL) Market: Sales Value (in Million USD), 2020 & 2025
Figure 12: Global: Intraocular Lens (Toric IOL) Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 13: Global: Intraocular Lens (Accommodative IOL) Market: Sales Value (in Million USD), 2020 & 2025
Figure 14: Global: Intraocular Lens (Accommodative IOL) Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 15: Global: Intraocular Lens (Polymethylmethacrylate-PMMA) Market: Sales Value (in Million USD), 2020 & 2025
Figure 16: Global: Intraocular Lens (Polymethylmethacrylate-PMMA) Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 17: Global: Intraocular Lens (Silicone) Market: Sales Value (in Million USD), 2020 & 2025
Figure 18: Global: Intraocular Lens (Silicone) Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 19: Global: Intraocular Lens (Hydrophobic Acrylic) Market: Sales Value (in Million USD), 2020 & 2025
Figure 20: Global: Intraocular Lens (Hydrophobic Acrylic) Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 21: Global: Intraocular Lens (Hospitals) Market: Sales Value (in Million USD), 2020 & 2025
Figure 22: Global: Intraocular Lens (Hospitals) Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 23: Global: Intraocular Lens (Ophthalmic Clinics) Market: Sales Value (in Million USD), 2020 & 2025
Figure 24: Global: Intraocular Lens (Ophthalmic Clinics) Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 25: Global: Intraocular Lens (Ambulatory Care Centers) Market: Sales Value (in Million USD), 2020 & 2025
Figure 26: Global: Intraocular Lens (Ambulatory Care Centers) Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 27: Global: Intraocular Lens (Eye Research Institutes) Market: Sales Value (in Million USD), 2020 & 2025
Figure 28: Global: Intraocular Lens (Eye Research Institutes) Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 29: North America: Intraocular Lens Market: Sales Value (in Million USD), 2020 & 2025
Figure 30: North America: Intraocular Lens Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 31: United States: Intraocular Lens Market: Sales Value (in Million USD), 2020 & 2025
Figure 32: United States: Intraocular Lens Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 33: Canada: Intraocular Lens Market: Sales Value (in Million USD), 2020 & 2025
Figure 34: Canada: Intraocular Lens Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 35: Asia-Pacific: Intraocular Lens Market: Sales Value (in Million USD), 2020 & 2025
Figure 36: Asia-Pacific: Intraocular Lens Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 37: China: Intraocular Lens Market: Sales Value (in Million USD), 2020 & 2025
Figure 38: China: Intraocular Lens Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 39: Japan: Intraocular Lens Market: Sales Value (in Million USD), 2020 & 2025
Figure 40: Japan: Intraocular Lens Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 41: India: Intraocular Lens Market: Sales Value (in Million USD), 2020 & 2025
Figure 42: India: Intraocular Lens Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 43: South Korea: Intraocular Lens Market: Sales Value (in Million USD), 2020 & 2025
Figure 44: South Korea: Intraocular Lens Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 45: Australia: Intraocular Lens Market: Sales Value (in Million USD), 2020 & 2025
Figure 46: Australia: Intraocular Lens Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 47: Indonesia: Intraocular Lens Market: Sales Value (in Million USD), 2020 & 2025
Figure 48: Indonesia: Intraocular Lens Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 49: Others: Intraocular Lens Market: Sales Value (in Million USD), 2020 & 2025
Figure 50: Others: Intraocular Lens Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 51: Europe: Intraocular Lens Market: Sales Value (in Million USD), 2020 & 2025
Figure 52: Europe: Intraocular Lens Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 53: Germany: Intraocular Lens Market: Sales Value (in Million USD), 2020 & 2025
Figure 54: Germany: Intraocular Lens Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 55: France: Intraocular Lens Market: Sales Value (in Million USD), 2020 & 2025
Figure 56: France: Intraocular Lens Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 57: United Kingdom: Intraocular Lens Market: Sales Value (in Million USD), 2020 & 2025
Figure 58: United Kingdom: Intraocular Lens Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 59: Italy: Intraocular Lens Market: Sales Value (in Million USD), 2020 & 2025
Figure 60: Italy: Intraocular Lens Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 61: Spain: Intraocular Lens Market: Sales Value (in Million USD), 2020 & 2025
Figure 62: Spain: Intraocular Lens Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 63: Russia: Intraocular Lens Market: Sales Value (in Million USD), 2020 & 2025
Figure 64: Russia: Intraocular Lens Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 65: Others: Intraocular Lens Market: Sales Value (in Million USD), 2020 & 2025
Figure 66: Others: Intraocular Lens Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 67: Latin America: Intraocular Lens Market: Sales Value (in Million USD), 2020 & 2025
Figure 68: Latin America: Intraocular Lens Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 69: Brazil: Intraocular Lens Market: Sales Value (in Million USD), 2020 & 2025
Figure 70: Brazil: Intraocular Lens Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 71: Mexico: Intraocular Lens Market: Sales Value (in Million USD), 2020 & 2025
Figure 72: Mexico: Intraocular Lens Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 73: Others: Intraocular Lens Market: Sales Value (in Million USD), 2020 & 2025
Figure 74: Others: Intraocular Lens Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 75: Middle East and Africa: Intraocular Lens Market: Sales Value (in Million USD), 2020 & 2025
Figure 76: Middle East and Africa: Intraocular Lens Market: Breakup by Country (in %), 2025
Figure 77: Middle East and Africa: Intraocular Lens Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 78: Global: Intraocular Lens Industry: SWOT Analysis
Figure 79: Global: Intraocular Lens Industry: Value Chain Analysis
Figure 80: Global: Intraocular Lens Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Intraocular Lens Market: Key Industry Highlights, 2025 and 2034
Table 2: Global: Intraocular Lens Market Forecast: Breakup by Product (in Million USD), 2026-2034
Table 3: Global: Intraocular Lens Market Forecast: Breakup by Material (in Million USD), 2026-2034
Table 4: Global: Intraocular Lens Market Forecast: Breakup by End Use (in Million USD), 2026-2034
Table 5: Global: Intraocular Lens Market Forecast: Breakup by Region (in Million USD), 2026-2034
Table 6: Global: Intraocular Lens Market: Competitive Structure
Table 7: Global: Intraocular Lens Market: Key Players

02-2729-4219

+886-2-2729-4219